Results 221 to 230 of about 85,963 (263)

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

International Journal of Molecular Sciences, 2021
Islam Md Asiful, P J Kotyla, Bartosz Wnuk   +2 more
exaly  

Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial

Journal of Allergy and Clinical Immunology, 2021
, Sarah Rardin, Jane R Kenny
exaly  

Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs

Current Medicinal Chemistry, 2022
Wen Zhang, Guo-Wu Rao, Minyan Zhao
exaly  

Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort study

Rheumatology, 2023
Shōichi Fukui, Naoki Iwamoto, Tomohisa Uchida   +2 more
exaly  

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

Cancers, 2020
Rami Komrokji, Gary W Reuther, Nathan P Horvat   +2 more
exaly  

Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells

International Journal of Molecular Sciences, 2021
Elena Vehns, Karima Djabali, Djabali Karima   +2 more
exaly  

Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor

Bioorganic and Medicinal Chemistry Letters, 2022
Manoranjan Sharma
exaly  

Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors

Clinical Rheumatology, 2022
Seokchan Hong, Bin Yoo, Yong-Gil Kim
exaly  

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review

Journal of Cutaneous Medicine and Surgery, 2023
Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung   +2 more
exaly  

JAK INHIBITORS

2020
MOHAN RAJU, NUSS JOHN, HARRIS JASON, YUAN SHENDONG   +3 more
openaire   +2 more sources